$5.3 Million in Series A Funding
On January 27, 2017, Leading healthcare IT company SnapMD, Inc., announced it completed the first closing of its Series A funding in the amount of $5.3 million. This round was completed with the help of Shea Ventures, TYLT Labs and Whittier Ventures. SnapMD’s Virtual Care Management telemedicine platform is the most important advances in patient-centric medicine today. VCM telemedicine technology offers healthcare providers powerful tools to extend the reach of patient care. In 2016 the number of patients accessing telehealth services is expected to double from that found in 2013. With this financing, SnapMD will accelerate its business development efforts in direct sales as well as high-valued channel partners. The company will also fortify its deep and detailed product developments plans that include core innovations to the company’s primary cloud-based Virtual Care Management (VCM) private-label telemedicine platform, expanded data integration capabilities and further scale its mobile app solutions.
SnapMD is the Virtual Care Management (VCM) telemedicine software leader, enabling healthcare providers to engage their patients via a secure, HIPAA compliant, cloud-based telemedicine platform. SnapMD’s robust, private-label, VCM application is specifically designed to give healthcare organizations another option to improve access to care by launching virtual care Telehealth services under their brand utilizing their highly qualified, patient-trusted providers.
You can find more information on SnapMD’s funding on SnapMD’s Website.